Recover blocked ITC on raw materials and active pharmaceutical ingredients (18% input) due to inverted duty structure on medicines (5-12% output).
The inverted duty structure under the GST can be an unnoticed consumer of a large amount of working capital for pharmaceutical manufacturers. The GST rate on raw materials, packaging materials, chemicals and active pharmaceutical ingredients is higher, and the GST rate on finished medicines is comparatively lower for companies. Pharma companies can avail of GST refund for this excess ITC under the provisions of Section 54(3).
Key Fact: APIs, packaging, machinery parts and other inputs used by pharma manufacturers are taxed at 12% or 18% GST, while finished formulations attract lower GST rates. This creates accumulated ITC under Rule 89(5), enabling refund claims and improving business liquidity.
Pharma manufacturers can claim GST refunds under Section 54(3) because many essential raw materials, active ingredients, packaging materials, and production inputs attract higher GST rates than the final medicines sold, resulting in accumulated input tax credit and blocked working capital.
Understanding GST on pharmaceutical raw materials is important as higher input tax and lower output tax create refund eligibility. Pharma manufacturer ITC refund India 2026 depends on correct HSN classification of raw materials, packaging, and finished drugs under GST rules.
| Item | HSN Code | GST Rate | Type |
|---|---|---|---|
| Active Pharmaceutical Ingredients (APIs) | 2941 | 18% | Input |
| Excipients & Additives | 3002 | 18% | Input |
| Finished Medicines | 3004 | 5% to 12% | Output |
| Packaging Materials | 4819 | 18% | Input |
| Capsules & Tablets Base | 3002 to 3006 | 18% | Input |
| Medical Devices / OTC | 9018 to 9027 | 12% | Output |
To submit your GST refund claim for pharmaceutical manufacturing and related products, you will need:
Active GST registration as a pharmaceutical manufacturer
GSTR-1 and GSTR-3B filed correctly, showing accumulated ITC on inputs.
Bills for used APIs, excipients, chemicals and packaging materials.
Tax invoices for finished medicines and pharmaceutical products sold.
Detailed calculation of input tax credit claimed on raw materials and inputs.
GMP approvals and other pharma compliance documents.
Yes! Several digital platforms now assist pharma manufacturers in efficiently processing GST refund applications with greater accuracy and reduced manual effort.
It is to be noted that the pharma manufacturers can directly file refund applications on the GST portal using Form RFD-01.
Can be used freely, but may be complicated.
These are dedicated platforms that assist pharmaceutical companies in preparing the documents, calculating refunds, and providing filing support.
Services that are payable, but better to deal with.
Many pharma manufacturers are using CA firms for GST refund applications, compliance audits, and addressing queries.
Paid services, but easier to manage
Our platform supports pharma manufacturers and ensures hassle-free eligibility checks, documentation, and refund filing.
For use in pharma companies.
GST registration as a pharma manufacturer, medicine, and healthcare product manufacturer.
Accumulated ITC from inverted duty structure pharma manufacturing GST on APIs and formulation equipment.
GSTR-1 and GSTR-3B returns were properly filed and updated for the previous financial periods.
Monthly Pharma Sales
₹50,00,000
ITC on Raw Materials and Packaging Inputs (18%)
₹9,00,000
Output GST on Finished Medicines (5%)
₹2,50,000
Eligible Refund Amount = ₹9,00,000 - ₹2,50,000 = ₹6,50,000
This accumulated ITC can be claimed as a refund under Section 54(3) for pharma manufacturers.
*Final refund amount may vary depending on compliance records and case-specific details.
Unclaimed ITC can quietly lock up a huge part of your working capital. Our team has already helped 150+ pharma manufacturers recover over ₹50 crore in GST refunds under Section 54(3).
Off on consultation charges for pharma manufacturers filing GST refund claims this quarter
*Terms apply
Complete documentation assistance, including RFD-01 filing, application review, and department follow-up for pharma businesses
*Expert verification included
Successful pharma refund approvals processed this year with an average refund value of ₹95 lakh per manufacturer
*Trusted industry experience
Quick eligibility review for pharma manufacturers.
Our team organises and prepares all required records.
RFD-01 application filed accurately on the GST portal.
Refund amount processed directly to your bank account.
GST refund for pharmaceutical manufacturers in India refers to refund of accumulated ITC due to higher GST on inputs like APIs and packaging at 18% compared to finished medicines taxed at 5%, creating unutilized credit eligible for refund.